Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients

por Framery, Bérénice, Gutowski, Marian, Dumas, Karen, Evrard, Alexandre, Muller, Nathalie, Dubois, Vincent, Quinonero, Jérôme, Scherninski, François, Pèlegrin, André, Cailler, Françoise
Publicado 2019

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agen...

por Hoogstins, Charlotte E. S., Boogerd, Leonora S. F., Sibinga Mulder, Babs G., Mieog, J. Sven D., Swijnenburg, Rutger Jan, van de Velde, Cornelis J. H., Farina Sarasqueta, Arantza, Bonsing, Bert A., Framery, Berenice, Pèlegrin, André, Gutowski, Marian, Cailler, Françoise, Burggraaf, Jacobus, Vahrmeijer, Alexander L.
Publicado 2018

Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer

por de Valk, Kim S., Deken, Marion M., Schaap, Dennis P., Meijer, Ruben P., Boogerd, Leonora S., Hoogstins, Charlotte E., van der Valk, Maxime J., Kamerling, Ingrid M., Bhairosingh, Shadhvi S., Framery, Bérénice, Hilling, Denise E., Peeters, Koen C., Holman, Fabian A., Kusters, Miranda, Rutten, Harm J., Cailler, Françoise, Burggraaf, Jacobus, Vahrmeijer, Alexander L.
Publicado 2020